The modern era has brought an appreciation that renal cell carcinoma (RCC) includes diverse subtypes derived from the various parts of the nephron, each with its distinctive genetic basis and tumor biology. Carcinoma of the collecting ducts of Bellini (CDC) is a rare subtype of RCC, with a predictably poor prognosis. This rare subtype represents less than 1% of all kidney carcinomas. It derives from presumably numerous chromosomal losses. It is of chief importance to differentiate CDC from other types of renal cell cancer. Typically, it is characterized by a firm, centrally located tumor with infiltrative borders. Regarding the histopathologic characteristics, we can find complex, highly infiltrative cords with inflamed (desmoplastic) strom...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma (RCC) of collec...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Bellini's duct carcinoma (BDC) is a rare and aggressive variant of renal cell carcinoma that po...
We present a rare clinical case of renal cell carcinoma from the collection tubules-carcinoma of Bel...
Introduction Though uncommon, the collecting duct carcinoma (CDC) of Bellini is a very aggressive pr...
Background. Collecting (Bellini) duct carcinoma (CDC) or Bellini duct carcinoma (BDC) is a rare subt...
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising ...
ABSTRACTCollecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. T...
To study the clinicopathologic characteristics of renal collecting duct carcinoma (CDC).A retrospect...
Item does not contain fulltextOBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but...
Carcinoma of the collecting ductsof Bellini isa rare histological subtype of renal cell carcinoma an...
OBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but reportedly aggressive histolo...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma (RCC) of collec...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare aggressive neopl...
Bellini's duct carcinoma (BDC) is a rare and aggressive variant of renal cell carcinoma that po...
We present a rare clinical case of renal cell carcinoma from the collection tubules-carcinoma of Bel...
Introduction Though uncommon, the collecting duct carcinoma (CDC) of Bellini is a very aggressive pr...
Background. Collecting (Bellini) duct carcinoma (CDC) or Bellini duct carcinoma (BDC) is a rare subt...
Collecting duct carcinoma (CDC) is a rare and aggressive form of renal cell carcinoma (RCC) arising ...
ABSTRACTCollecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. T...
To study the clinicopathologic characteristics of renal collecting duct carcinoma (CDC).A retrospect...
Item does not contain fulltextOBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but...
Carcinoma of the collecting ductsof Bellini isa rare histological subtype of renal cell carcinoma an...
OBJECTIVES: Collecting duct renal cell carcinoma (CDRCC) is a rare but reportedly aggressive histolo...
SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm that ar...
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma (RCC) of collec...
Renal cell carcinoma (RCC) represents 2-3% of all malignancies and approximately 50% of patients dev...